Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2014
Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy
David J Mulvihill, Kevin McMichael, Sharad Goyal, et al.
Current Oncology Reports
|
June 5, 2014
Advances in therapy for pediatric sarcomas
Aaron Weiss, Jonathan Gill, John Goldberg, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 15, 2024
SciScribe: Automating and contextualizing literature reviews in cardiac surgery
Rashed Mahboubi, Kasper Dinkla, Aaron Weiss, et al.
The Journal of Biological Chemistry
|
January 16, 2009
mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability
Norman Balcazar, Aruna Sathyamurthy, Lynda Elghazi, et al.
Oncotarget
|
June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
British Journal of Cancer
|
March 16, 2021
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
Monika Sparber-Sauer, Daniel Orbach, Fariba Navid, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2008
Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner
Latif Rachdi, Norman Balcazar, Fernando Osorio-Duque, et al.
Oncotarget
|
May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Sebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
Cancer
|
March 14, 2007
Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience
Aaron Weiss, Joseph D Khoury, Fredric A Hoffer, et al.
Pediatric Blood & Cancer
|
February 7, 2022
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
Josephine H Haduong, Christine M Heske, Wendy Allen-Rhoades, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2014
Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy
David J Mulvihill, Kevin McMichael, Sharad Goyal, et al.
Current Oncology Reports
|
June 5, 2014
Advances in therapy for pediatric sarcomas
Aaron Weiss, Jonathan Gill, John Goldberg, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 15, 2024
SciScribe: Automating and contextualizing literature reviews in cardiac surgery
Rashed Mahboubi, Kasper Dinkla, Aaron Weiss, et al.
The Journal of Biological Chemistry
|
January 16, 2009
mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability
Norman Balcazar, Aruna Sathyamurthy, Lynda Elghazi, et al.
Oncotarget
|
June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
British Journal of Cancer
|
March 16, 2021
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
Monika Sparber-Sauer, Daniel Orbach, Fariba Navid, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2008
Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner
Latif Rachdi, Norman Balcazar, Fernando Osorio-Duque, et al.
Oncotarget
|
May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Sebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
Cancer
|
March 14, 2007
Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience
Aaron Weiss, Joseph D Khoury, Fredric A Hoffer, et al.
Pediatric Blood & Cancer
|
February 7, 2022
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
Josephine H Haduong, Christine M Heske, Wendy Allen-Rhoades, et al.
Page
of 4